Karen Fallen

Leniobio GmbH is a German protein expression platform company that focuses on the discovery, development, and large-scale production of proteins. The company was established in September 2016 and has offices in Dusseldorf and R&D and production labs in Aachen. Leniobio is redefining biopharma manufacturing and believes in providing equal opportunities for everyone to lead a healthy life. The company was founded by Remberto Martis, and André Goerke has been the CEO since 2023.

Leniobio GmbH is a German protein expression platform company that focuses on the discovery, development, and large-scale production of proteins. The company was established in September 2016 and has offices in Dusseldorf and R&D and production labs in Aachen. Leniobio is redefining biopharma manufacturing and believes in providing equal opportunities for everyone to lead a healthy life. The company was founded by Remberto Martis, and André Goerke has been the CEO since 2023.

Touchlight Genetics Ltd. operates as a biotechnology company. It develops an enzymatic means of DNA scale production addresses the limitations of plasmid DNA and meets the growing demands of DNA revolution. It offers DNA enables therapeutics, direct DNA therapeutics, and DNA nanotechnology. The company was founded by jonny Ohlson in 2008 and is headquartered in Hamptonl, the United Kingdom.

Touchlight Genetics Ltd. operates as a biotechnology company. It develops an enzymatic means of DNA scale production addresses the limitations of plasmid DNA and meets the growing demands of DNA revolution. It offers DNA enables therapeutics, direct DNA therapeutics, and DNA nanotechnology. The company was founded by jonny Ohlson in 2008 and is headquartered in Hamptonl, the United Kingdom.

Leniobio GmbH is a German protein expression platform company that focuses on the discovery, development, and large-scale production of proteins. The company was established in September 2016 and has offices in Dusseldorf and R&D and production labs in Aachen. Leniobio is redefining biopharma manufacturing and believes in providing equal opportunities for everyone to lead a healthy life. The company was founded by Remberto Martis, and André Goerke has been the CEO since 2023.

Touchlight Genetics Ltd. operates as a biotechnology company. It develops an enzymatic means of DNA scale production addresses the limitations of plasmid DNA and meets the growing demands of DNA revolution. It offers DNA enables therapeutics, direct DNA therapeutics, and DNA nanotechnology. The company was founded by jonny Ohlson in 2008 and is headquartered in Hamptonl, the United Kingdom.

Touchlight Genetics Ltd. operates as a biotechnology company. It develops an enzymatic means of DNA scale production addresses the limitations of plasmid DNA and meets the growing demands of DNA revolution. It offers DNA enables therapeutics, direct DNA therapeutics, and DNA nanotechnology. The company was founded by jonny Ohlson in 2008 and is headquartered in Hamptonl, the United Kingdom.